Literature DB >> 32808236

Prognostic Factors of Long-term Survival Following Radical Resection for Ampullary Carcinoma.

Daniel Weiss Vilhordo1, Cleandra Gregório2, Dirceu Felipe Valentini3, Maria Isabel Albano Edelweiss4, Diego Mendonça Uchoa4, Alessandro Bersch Osvaldt1,5.   

Abstract

BACKGROUND: The incidence of adenocarcinoma of the ampulla of Vater has been increasing over the past years. Nevertheless, it is still a rare disease and the prognostic factors predicting long-term survival are not sufficiently clarified. This study aims to evaluate the association between histopathological characteristics and long-term survival of patients with ampullary cancer after curative resection, as well as the efficiency of immunohistochemical expression of CK7, CK20, and CDX2 to distinguish the histopathological (intestinal or pancreaticobiliary) patterns.
METHODS: Demographic, histopathological data, pTNM stage, and immunohistochemical expression patterns were collected from 65 patients with adenocarcinoma of the ampulla of Vater. Five and 10-year overall and disease-free survival rates after curative resection were determined.
RESULTS: Of the 65 patients with ampullary carcinoma, 47 (72%) underwent radical resection. The 5- and 10-year overall survival rate was 46% and 37%, respectively. Our results demonstrate that the main prognostic factors were the presence and number of lymph node metastases, lymph node ratio (LNR), differentiation grade, and lymphovascular invasion. After multivariate analysis, only lymph node ratio ≥ 20% remained an independent prognostic factor of survival (HR: 2.63 95% CI: 1.05-6.61; p = 0.039).
CONCLUSION: Here, we demonstrated more evidence that the lymph node metastases are associated with poor prognosis in ampullary carcinoma. Particularly, the relation between the number of metastatic lymph nodes and the number of harvested lymph node (LNR) should be considered a major prognostic factor.
© 2020. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Ampullary carcinoma; Immunohistochemistry; Long-term survival; Lymph node ratio

Mesh:

Substances:

Year:  2021        PMID: 32808236     DOI: 10.1007/s12029-020-00479-9

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  47 in total

1.  Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up.

Authors:  Hui Zhou; Nico Schaefer; Martin Wolff; Hans-Peter Fischer
Journal:  Am J Surg Pathol       Date:  2004-07       Impact factor: 6.394

2.  Assessment of Lymph Node Ratio to Replace the pN Categories System of Classification of the TNM System in Esophageal Squamous Cell Carcinoma.

Authors:  Yingjie Shao; Yiting Geng; Wendong Gu; Zhonghua Ning; Jin Huang; Honglei Pei; Jingting Jiang
Journal:  J Thorac Oncol       Date:  2016-07-05       Impact factor: 15.609

3.  Predictors for patterns of failure after pancreaticoduodenectomy in ampullary cancer.

Authors:  Hui-Ping Hsu; Ta-Ming Yang; Yu-Hsiang Hsieh; Yan-Shen Shan; Pin-Wen Lin
Journal:  Ann Surg Oncol       Date:  2006-10-20       Impact factor: 5.344

4.  Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up.

Authors:  Taylor S Riall; John L Cameron; Keith D Lillemoe; Jordan M Winter; Kurtis A Campbell; Ralph H Hruban; David Chang; Charles J Yeo
Journal:  Surgery       Date:  2006-08-28       Impact factor: 3.982

5.  Cancers of the ampulla of vater: demographics, morphology, and survival based on 5,625 cases from the SEER program.

Authors:  Jorge Albores-Saavedra; Arnold M Schwartz; Kristen Batich; Donald E Henson
Journal:  J Surg Oncol       Date:  2009-12-01       Impact factor: 3.454

6.  Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosis.

Authors:  Jordan M Winter; John L Cameron; Kelly Olino; Joseph M Herman; Mechteld C de Jong; Ralph H Hruban; Christopher L Wolfgang; Frederic Eckhauser; Barish H Edil; Michael A Choti; Richard D Schulick; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2010-02       Impact factor: 3.452

7.  Negative to positive lymph node ratio is a superior predictor than traditional lymph node status in stage III colorectal cancer.

Authors:  Qingguo Li; Lei Liang; Huixun Jia; Xinxiang Li; Ye Xu; Ji Zhu; Sanjun Cai
Journal:  Oncotarget       Date:  2016-11-01

8.  Survival Outcomes According to Adjuvant Treatment and Prognostic Factors Including Host Immune Markers in Patients with Curatively Resected Ampulla of Vater Cancer.

Authors:  Hye Rim Ha; Do-Youn Oh; Tae-Yong Kim; KyoungBun Lee; Kyubo Kim; Kyung-Hun Lee; Sae-Won Han; Eui Kyu Chie; Jin-Young Jang; Seock-Ah Im; Tae-You Kim; Sun-Whe Kim; Yung-Jue Bang
Journal:  PLoS One       Date:  2016-03-14       Impact factor: 3.240

9.  Superiority of lymph node ratio-based staging system for prognostic prediction in 2575 patients with gastric cancer: validation analysis in a large single center.

Authors:  Lin-Yong Zhao; Chang-Chun Li; Lu-Yu Jia; Xiao-Long Chen; Wei-Han Zhang; Xin-Zu Chen; Kun Yang; Kai Liu; Yi-Gao Wang; Lian Xue; Bo Zhang; Zhi-Xin Chen; Jia-Ping Chen; Zong-Guang Zhou; Jian-Kun Hu
Journal:  Oncotarget       Date:  2016-08-09

10.  Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater.

Authors:  W Kimura; N Futakawa; S Yamagata; Y Wada; A Kuroda; T Muto; Y Esaki
Journal:  Jpn J Cancer Res       Date:  1994-02
View more
  3 in total

1.  Prognostic Value of the Regional Lymph Node Station in Pancreatoduodenectomy for Ampullary Carcinoma.

Authors:  Kosei Takagi; Yasuo Nagai; Yuzo Umeda; Ryuichi Yoshida; Kazuhiro Yoshida; Tomokazu Fuji; Kenjiro Kumano; Kazuya Yasui; Takahito Yagi; Toshiyoshi Fujiwara
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

2.  Clinicopathological Prognostic Factors and Chemotherapeutic Outcome for Two Histopathological Types of Ampulla of Vater Adenocarcinoma.

Authors:  Tao Xia; Xiaosan Wu; Yiping Mou; Yunyun Xu; Yucheng Zhou; Chao Lu; Qicong Zhu; Weiwei Jin; Yuan Chen
Journal:  Front Oncol       Date:  2021-02-18       Impact factor: 6.244

3.  Screening for hilar biliary invasion in ampullary cancer patients.

Authors:  Tadayuki Takagi; Mitsuru Sugimoto; Rei Suzuki; Naoki Konno; Hiroyuki Asama; Yuki Sato; Hiroki Irie; Jun Nakamura; Mika Takasumi; Minami Hashimoto; Tsunetaka Kato; Ryoichiro Kobashi; Takumi Yanagita; Yuko Hashimoto; Shigeru Marubashi; Takuto Hikichi; Hiromasa Ohira
Journal:  World J Gastrointest Endosc       Date:  2022-09-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.